Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Prevalence of bowel urgency and its association with quality of life and disease severity among patients with inflammatory bowel disease: results from the real-world measuring urgency symptoms in inflammatory bowel disease collaboration (MUSIC) online study.
Journal: Current medical research and opinion
Published: January 08, 2026
Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study.
Journal: Inflammatory bowel diseases
Published: September 08, 2025
Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers.
Journal: The American journal of gastroenterology
Published: August 04, 2025
Mirikizumab impact on disease clearance in patients with moderately to severely active ulcerative colitis: analysis of a pre-specified LUCENT trial endpoint.
Journal: Journal of Crohn's & colitis
Published: July 12, 2025
Mirikizumab Long-Term Efficacy and Safety in Patients With Crohn's Disease: Results From the VIVID-2 Open-Label Extension Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 20, 2025
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab.
Journal: Journal of patient-reported outcomes
Published: March 20, 2025
Real-World Dose Escalation and Associated Direct Costs of Biologics in Management of Ulcerative Colitis: A Retrospective Database Study.
Journal: Digestive diseases (Basel, Switzerland)
Published: December 26, 2024
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 21, 2024
Bowel Urgency Severity Among Patients with Crohn's Disease or Ulcerative Colitis on Advanced Therapies: Real-World Data Using Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease.
Journal: Gastro hep advances
Published: October 01, 2024
Exploring patient-reported outcome measures to assess symptoms of moderately-to-severely active Crohn's disease in adult and adolescent patients: a qualitative study.
Journal: Journal of patient-reported outcomes
Published: September 05, 2024
Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.
Journal: Crohn's & colitis 360
Published: August 30, 2024
Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.
Journal: The American journal of gastroenterology
Published: July 30, 2024
Last Updated: 09/26/2026